OACCW Oaktree Acquisition Corp. III Life Sciences
Financial Services$0.87+11.54%ClosedMarket Cap: $21.4M
As of 2026-05-25
Valuation
View DetailsP/E (TTM)
2.68
PEG
—
P/B
1.05
P/S
0.00
EV/EBITDA
-216.80
DCF Value
—
FCF Yield
-0.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
3.6%
ROA
3.4%
ROIC
-0.6%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $0.00 | $1.4M | $— |
| Q4 null | $0.00 | $1.8M | $— |
| FY null | $0.00 | $7.3M | $— |
| Q3 null | $0.00 | $2.0M | $— |
Trading Activity
Insider Trades
View AllMartinez George Arthur
SellWed Oct 29
BERRY DAVID A
SellWed Oct 22
Sweeney Thomas
SellMon Jun 16
Oaktree Acquisition Holdings III LS, LLC10 percent owner
SellThu Oct 31
Oaktree Acquisition Holdings III LS, LLC10 percent owner
SellThu Oct 31
Company Info
Sector
Financial Services
Industry
Shell Companies
Country
US
Exchange
—
Beta
0.94
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.